Is Mirion Technologies a Good Pick After Recent Medical Imaging Partnership?
Mirion Technologies, Inc. Class A MIR | 19.00 | +1.82% |
- Ever wondered if Mirion Technologies is offering great value, or if this growth story is already reflected in the share price? Let’s break down what really matters for investors looking to buy or hold.
- While Mirion’s share price surged 308.5% over the last 3 years and is up 44.1% year-to-date, it recently took a 10.1% dip over the past week, which may indicate shifting market sentiment.
- News such as Mirion finalizing new partnerships in the medical imaging space and expanding its footprint in nuclear safety have caught investor attention. This has fueled optimism but also raised questions about execution risks, helping to explain both the recent rallies and the latest pullback.
- Currently, Mirion scores a 3 out of 6 on our valuation checks. This suggests there’s room for further assessment. We’ll explore different methods to value Mirion, and at the end, reveal an even more insightful way to judge whether this stock is truly a bargain.
Approach 1: Mirion Technologies Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting the future cash flows it is expected to generate and then discounting those cash flows back to their present value. This method provides a fundamental, long-term view of what a company is worth based on its ability to produce cash over time.
For Mirion Technologies, the DCF model projects Free Cash Flow (FCF) growth from its current level of approximately $86.8 million to an estimated $675.9 million by 2035. While analysts offer concrete forecasts for the next five years, further projections rely on financial extrapolation. According to the latest calculation using the 2 Stage Free Cash Flow to Equity model, the estimated intrinsic value of Mirion stands at $33.89 per share.
This valuation suggests a 28.0% discount compared to the current share price. This indicates the market could be significantly undervaluing Mirion based on these long-range cash flow projections. As with all models, these values depend on the accuracy of future assumptions, but the current DCF result paints an optimistic outlook.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Mirion Technologies is undervalued by 28.0%. Track this in your watchlist or portfolio, or discover 901 more undervalued stocks based on cash flows.
Approach 2: Mirion Technologies Price vs Sales
The Price-to-Sales (P/S) ratio is a useful valuation metric, especially when analyzing companies like Mirion Technologies that are investing heavily in growth and may not show large profits yet. The P/S ratio can give a clearer sense of value for such companies, as it focuses on revenue rather than earnings, making it less susceptible to accounting differences or short-term profitability swings.
Higher growth prospects or lower risk typically justify a higher P/S ratio. In contrast, slower growth or elevated risk often mean a lower "fair" multiple. Mirion trades at a P/S ratio of 6.19x, which is substantially above both the Electronic industry average of 2.56x and the peer average of 2.93x. At first glance, this suggests the stock is priced at a premium compared to similar companies.
However, Simply Wall St's proprietary “Fair Ratio” provides a more nuanced perspective. Rather than focusing solely on raw industry or peer comparisons, the Fair Ratio evaluates the multiple Mirion should have based on its own growth outlook, profit margins, risks, market cap, and industry context. For Mirion Technologies, the Fair Ratio is 4.56x. This means the current P/S ratio is still above what would be considered fair value given its fundamentals.
Since Mirion's P/S ratio is more than 0.10 higher than the Fair Ratio, the stock appears to be trading above fair value based on this metric and analysis.
Result: OVERVALUED
PS ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1422 companies where insiders are betting big on explosive growth.
Upgrade Your Decision Making: Choose your Mirion Technologies Narrative
Earlier we mentioned that there's a better way to understand valuation, so let's introduce you to Narratives. Simply put, a Narrative is your story behind the numbers, providing a way to connect what you believe about a company, like Mirion Technologies’ growth or risks, to a concrete financial forecast and a fair value estimate. On Simply Wall St’s Community page, millions of investors can use Narratives to easily capture and communicate their conviction, showing how their expectations for future revenues, margins, and fair value align with what’s happening in the real world.
Narratives help you clearly see when your estimated fair value justifies buying or selling, compared to today’s price, and they update instantly as new news or earnings are released, reflecting the latest outlook and opportunity. For example, some investors see Mirion riding the expansion of nuclear power and digital solutions to reach a fair value of $26.00 per share, while more cautious users, focused on regulatory and integration risks, set their fair value as low as $22.00 per share. Each narrative shows how the company’s journey, financials, and market realities interact. Narratives turn complex numbers into actionable insights, making your investment process smarter and more responsive.
Do you think there's more to the story for Mirion Technologies? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
